Article thumbnail

Comparison of Radioimmuno and Carbon Nanotube Field-Effect Transistor Assays for Measuring Insulin-Like Growth Factor-1 in a Preclinical Model of Human Breast Cancer

By Laundette P Jones, Steingrimur Stefansson, Man S Kim and Saeyoung N Ahn
Topics: Short Communication
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3182969
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2007). Absence of the common IGF1 19 CA-repeat allele is more common among BRCA1 mutation carriers than among non-carriers from BRCA1 families. Fam Cancer
  2. (2007). CF: Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations. Endocr Relat Cancer
  3. (2006). Deng C: Absence of the Full-Length Breast Cancer-Associated Gene-1 Leads to Increased Expression of Insulin-Like Growth Factor Signaling Axis Members. Cancer Res
  4. (1999). Deng CX: Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet
  5. (2001). Deng CX: Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice. Oncogene
  6. (2007). Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations. Cancer Lett
  7. (2010). Endogenous Hormones and Breast Cancer Collaborative Group: Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol
  8. (2006). Flyvbjerg A: Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab
  9. (2004). Foulkes WD: BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer
  10. (2005). Kaaks R: IGF-I, IGFBP-3 and breast cancer in young women: a pooled re-analysis of three prospective studies.
  11. (2005). PA: Promotion of mammary cancer development by temoxifen in a mouse model of Brca1-mutation-related breast cancer. Oncogene
  12. (2000). SG: IGF and insulin action in the mammary gland: lessons from transgenic and knockout models.
  13. (1997). The BRCA1 and BRCA2 breast cancer genes. Curr Opin Oncol